Welcome to the online home of the Chris M. Carlos and Catherine Nicole Jockisch Carlos Endowment for Primary Sclerosing Cholangitis (PSC). Thanks to support provided by this endowment, dedicated Mayo Clinic investigators and their teams are making strides to better understand and treat PSC patients, with the ultimate goal of developing a cure for this disease.
Follow the PSC page and stay up-to-date as we post news about advances in PSC research, clinical trials, and available resources.
Feb 1, 2021 | Konstantinos N. Lazaridis, M.D. | @klazaridis
Absence of medical therapy for primary sclerosing cholangitis (PSC) leads to end-stage liver disease requiring liver transplantation (LT). However, studies specifically evaluating whether ethnic disparities…